Startup India Government of India
Acculi Labs Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹15.75 Lakh
▲ 29% YoY
Net loss · FY 2022
₹46.44 Lakh
Net margin -294.8%
EBITDA · FY 2022
-₹41.59 Lakh
EBITDA margin -264%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.36 Lakh
Issued & subscribed
Open charges
₹22 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Acculi Labs Private Limited
Data last updated:
Acculi Labs Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72900KA2017PTC103431. Its GSTIN is 29AAPCA6376B1ZE (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.36 Lakh. It is led by directors including Rupam Das and Akbar.
Its last annual general meeting (AGM) was held on 13 February 2023, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.75 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹46.44 Lakh (net margin -294.8%) and EBITDA of -₹41.59 Lakh (EBITDA margin -264%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
The company is associated with 2 brands: Acculi and Lyfas. As per MCA filings, the company has open charges of ₹22 Lakh on record. The company has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acculi.com.
Company details
CIN U72900KA2017PTC103431
Registration Number 103431
Incorporation Date 30 May 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 13 February 2023
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Rupam Das Director Akbar Director Moumita Das Director Recognitions & Rankings of Acculi Labs
Contact details
Acculi Labs Private Limited's registered office is in Bangalore, Karnataka. Its website is acculi.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.31 Ground Floor 3rd Cross Basappa Layout Behind L.G.Godown Pattanagere Rajarajeshwari N, Agar, Bangalore, Karnataka, India – 560098
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Acculi Labs Private Limited, buy the company report.
Comprehensive company report
Acculi Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Acculi Labs operates two associated brands: Acculi and Lyfas. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of AI-based predictive and preventive digital health test and home remedy | lyfas.com | |
| Limited information available | acculi.com |
Business activity
The main business activity of Acculi Labs is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Acculi Labs Private Limited, buy the company report.
Financials of Acculi Labs Private Limited
FY 2022 filings availableAcculi Labs Private Limited reported revenue of ₹15.75 Lakh (up 29% YoY) for FY 2022.
Revenue · FY 2022
₹15.75 Lakh ▲ 29%
Net loss · FY 2022
₹46.44 Lakh margin -294.8%
EBITDA · FY 2022
-₹41.59 Lakh margin -264%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▼ 29%
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 29% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹15.75 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹41.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹46.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -264% | ||||
| Net Profit Margin | -294.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Acculi Labs Private Limited, buy the company report.
Board of directors of Acculi Labs Private Limited
Acculi Labs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupam Das Also directs: Paio Investment Consultancy Private Limited | Director | 30 May 2017 | 9 Years 4 Months | Current |
| Akbar | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Moumita Das Also directs: Subhankar Sports Private Limited | Director | 30 May 2017 | 9 Years 4 Months | Current |
Auditor
Acculi Labs Private Limited is audited by AVINASH N & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVINASH N & ASSOCIATES | FY 2022 | 245573 |
Shareholding
The shareholding of Acculi Labs Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Acculi Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Feb 2021 | 100411599 | Others | ₹22 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Acculi Labs Private Limited has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024.
Total deals
14
Funding rounds
11
Secondary share transfers
3
Disclosed funding
₹14.65 Cr
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Funding round · Seed | ₹12.55 Cr | Investors: Sabi Holding India Limited |
| Oct 2022 | Funding round | ₹4.9 Lakh | Investors: Startup Incubation and Innovation Centre- IIT Kanpur |
| May 2022 | Funding round | ₹8.2 Lakh | Investors: 3 individuals |
| May 2022 | Funding round | ₹18 Lakh | Investors: an individual |
| Apr 2022 | Funding round | ₹4.3 Lakh | Investors: 4 individuals |
To see the full deal history of Acculi Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Acculi Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acculi Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Acculi Labs Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Acculi Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAPCA6376B1ZE | Karnataka | Active | 09 May 2018 |
To see the full GST registrations and return filing status of Acculi Labs Private Limited, buy the company report.
Recent activity
Acculi Labs Private Limited has 13 board changes on record since 2017: 8 appointments and 5 cessations. The latest: Amit Mogra ceased to be Additional Director on 29 Jul 2022.
AGM
Acculi Labs Private Limited last Annual general meeting of members was held on 13 Feb 2023 as per latest MCA records.
Ceased
Amit Mogra ceased to be Additional Director.
Appointed
Amit Mogra was appointed as Additional Director.
Filing
Acculi Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Manjula Jeevanna ceased to be Additional Director.
Ceased
Helavarahundi Mahadevappa Geetha ceased to be Nominee Director.
Appointed
Manjula Jeevanna was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 22.00 Lakh with Charge ID 100411599 was registered on 08 Feb 2021.
Appointed
Helavarahundi Mahadevappa Geetha was appointed as Nominee Director.
Appointed
Akbar was appointed as Director.
Ceased
Hari Prasath ceased to be Director.
Ceased
Praveen Ramamurthy ceased to be Director.
5 earlier events are in the company report.
News
Frequently asked questions
Acculi Labs is an active private limited company based in Bangalore, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 May 2017 (9+ years old) and is registered under CIN U72900KA2017PTC103431.
Acculi Labs has 3 current directors:
- Rupam Das - Director
- Akbar - Director
- Moumita Das - Director
The latest financial statements of Acculi Labs on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 13 February 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Acculi Labs is 29AAPCA6376B1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Acculi Labs is U72900KA2017PTC103431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acculi Labs was incorporated on 30 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
Acculi Labs has 14 deals on record (11 funding rounds, 3 secondary share transfers), with disclosed funding of ₹14.65 Cr; the latest was in August 2024.
Amit Mogra ceased to be Additional Director on 29 Jul 2022. Amit Mogra was appointed as Additional Director on 17 May 2022. Manjula Jeevanna ceased to be Additional Director on 30 Nov 2021. Acculi Labs has 13 board changes on record in total.
Yes, Acculi Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Acculi Labs can be reached through the website acculi.com. Its registered office is in Bangalore, Karnataka, India.